###begin article-title 0
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 55 60 <span type="species:ncbi:10090">Mouse</span>
Suppression of Sproutys Has a Therapeutic Effect for a Mouse Model of Ischemia by Enhancing Angiogenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: KT HY TI HK YS MO YY AY. Performed the experiments: KT KiS KW TA FO RiK. Analyzed the data: KT KiS KW RiK. Contributed reagents/materials/analysis tools: KT TI RK. Wrote the paper: KT AY.
###end p 1
###begin p 2
###xml 283 291 283 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 296 304 296 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 495 503 495 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 547 555 547 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 658 666 658 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 742 750 742 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 755 763 755 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 775 782 775 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 995 1002 995 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 861 866 <span type="species:ncbi:10090">mouse</span>
Sprouty proteins (Sproutys) inhibit receptor tyrosine kinase signaling and control various aspects of branching morphogenesis. In this study, we examined the physiological function of Sproutys in angiogenesis, using gene targeting and short-hairpin RNA (shRNA) knockdown strategies. Sprouty2 and Sprouty4 double knockout (KO) (DKO) mice were embryonic-lethal around E12.5 due to cardiovascular defects. The number of peripheral blood vessels, but not that of lymphatic vessels, was increased in Sprouty4 KO mice compared with wild-type (WT) mice. Sprouty4 KO mice were more resistant to hind limb ischemia and soft tissue ischemia than WT mice were, because Sprouty4 deficiency causes accelerated neovascularization. Moreover, suppression of Sprouty2 and Sprouty4 expression in vivo by shRNA targeting accelerated angiogenesis and has a therapeutic effect in a mouse model of hind limb ischemia. These data suggest that Sproutys are physiologically important negative regulators of angiogenesis in vivo and novel therapeutic targets for treating peripheral ischemic diseases.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 204 207 204 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Kim1">[1]</xref>
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Cabrita1">[3]</xref>
###xml 735 738 731 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Takahashi1">[4]</xref>
Growth factor-induced signaling by receptor tyrosine kinases (RTKs) plays several essential roles in development and pathogenesis; accordingly, it is tightly controlled by a number of regulatory proteins [1]-[3]. When a ligand binds to an RTK and recruits a Grb2-Sos to the inner surface of a membrane, the Sos protein binds to Ras, causing GDP/GTP exchange and thus activating Ras. Activated Ras recruits Raf to the plasma membrane and activates the Raf/MEK/extracellular signal-regulated kinase (ERK) pathway. Some growth factors, such as vascular endothelial growth factor (VEGF)-A, also activate the Raf/MEK/ERK pathway through the RTK/phospholipase C (PLC)-gamma/protein kinase C (PKC) pathway, which is a Ras-independent pathway [4].
###end p 4
###begin p 5
###xml 134 144 134 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Hacohen1">[5]</xref>
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Casci1">[6]</xref>
###xml 267 285 267 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila Sprouty</italic>
###xml 287 297 287 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty1&#8211;4</italic>
###xml 320 323 320 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Kim1">[1]</xref>
###xml 325 328 325 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Mason1">[2]</xref>
###xml 516 519 516 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Wakioka1">[7]</xref>
###xml 521 524 521 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Kato1">[8]</xref>
###xml 566 572 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPRED1</italic>
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Brems1">[9]</xref>
###xml 134 144 <span type="species:ncbi:7227">Drosophila</span>
###xml 267 277 <span type="species:ncbi:7227">Drosophila</span>
###xml 597 602 <span type="species:ncbi:9606">human</span>
Sprouty (Spry) has been genetically identified as an antagonist of fibroblast growth factor (FGF) receptor in tracheal development in Drosophila, and is a proven negative regulator of the Ras/Raf/ERK pathway [5], [6]. Four mammalian genes with sequence similarity to Drosophila Sprouty (Sprouty1-4) have been identified [1], [2]. In addition, we have identified three Sprouty-related proteins known as Spred1-3 (Spreds), in which the C-terminal cysteine-rich domain found in Sprouty proteins (Sproutys) is conserved [7], [8]. Since loss-of-function mutations of the SPRED1 gene have been found in human neuro-cardio-facial-cutaneous (NCFC) syndromes [9], and since these syndromes are caused by dysregulation of the Ras-ERK pathway, we conclude that SPRED1 is a negative regulator of RTK-mediated Ras/ERK activation.
###end p 5
###begin p 6
###xml 51 61 51 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Flamme1">[10]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Flamme1">[10]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Folkman1">[11]</xref>
###xml 602 606 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Hanahan1">[12]</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Hanahan1">[12]</xref>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Shibuya1">[13]</xref>
###xml 954 958 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Hannun1">[14]</xref>
###xml 51 61 <span type="species:ncbi:7227">Drosophila</span>
In the development of the cardiovascular system of Drosophila, as in the tracheal system, the formation of new blood vessels from preexisting ones (angiogenesis) involves the sprouting of endothelial cells out of an epithelial layer and the branching of tubular structures [10]. In the adult, angiogenesis only takes place during the female reproductive cycle, during wound healing, and in pathological situations, including tumor growth, diabetic retinopathy, arthritis, atherosclerosis, and psoriasis [10], [11]. Angiogenesis is tightly regulated by a balance between inducing and inhibitory signals [12]. Growth factors, such as VEGF-A, basic FGF (bFGF), and angiopoietins, positively regulate angiogenesis by binding to their cognate RTKs and thus inducing endothelial cell proliferation, migration, differentiation, and survival [12], [13]. In addition, sphingosine-1-phosphate (S1P), which activates GPCRs, has also been implicated in angiogenesis [14]. In contrast, proteins that negatively regulate angiogenesis by specifically blocking RTK signaling are less well characterized.
###end p 6
###begin p 7
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 213 220 213 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Impagnatiello1">[15]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Lee1">[16]</xref>
###xml 303 311 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sasaki1">[17]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Ayada1">[19]</xref>
###xml 437 450 437 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spred1/Spred2</italic>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
Previous studies have demonstrated that overexpression of Sproutys inhibits VEGF-A- and bFGF-induced endothelial cell proliferation and differentiation in vitro as well as branching and sprouting of small vessels in vivo[15], [16]. Moreover, Sprouty4 suppresses VEGF-A/VEGF receptor (VEGFR)-2 signaling in vitro[17]-[19]. We also know that Spreds, in contrast, inhibit VEGF-C signaling, which is important in lymphangiogenesis, and that Spred1/Spred2 double knockout (KO) (DKO) mice show abnormal lymphatic development [18]. Yet the physiological role of Sproutys in angiogenesis and lymphangiogenesis remains to be elucidated.
###end p 7
###begin p 8
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 239 246 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 258 266 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 377 384 377 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 414 422 414 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 584 591 584 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 453 458 <span type="species:ncbi:10090">mouse</span>
In this study we investigated the physiological function of Sproutys in angiogenesis by performing knockout and knockdown analyses of Sproutys. We showed that Sproutys are negative regulators for angiogenesis rather than lymphangiogenesis in vivo. Moreover, Sprouty4 KO mice were more resistant to hind limb ischemia and soft tissue ischemia than wild-type (WT) mice were, and in vivo shRNA targeting Sprouty2 and Sprouty4 accelerated angiogenesis in a mouse model of hind limb ischemia. These data suggest that Sprouty2 and Sprouty4 are important negative regulators of angiogenesis in vivo that could be new therapeutic targets for ischemic diseases.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty</italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Increased developmental angiogenesis in Sprouty-deficient mice
###end title 10
###begin p 11
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sasaki2">[20]</xref>
###xml 203 220 203 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 231 248 231 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi2">[21]</xref>
###xml 439 448 439 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g001">Fig. 1A&#8211;D</xref>
###xml 485 494 485 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g001">Fig. 1E,F</xref>
###xml 606 614 606 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 619 627 619 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 694 702 694 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 707 715 707 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 821 828 821 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g001">Fig. 1G</xref>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
Overexpression studies suggest that Sprouty2 and Sprouty4 possess similar negative effects on RTK-mediated ERK activation [20]. To define the overlapping functions of Sprouty2 and Sprouty4, we generated Sprouty2/Sprouty4 DKO mice. Sprouty2/Sprouty4 DKO mice were embryonic-lethal by embryonic day 12.5 and showed very severe defects in craniofacial and limb morphogenesis [21]. They also showed very severe subcutaneous hemorrhage, edema (Fig. 1A-D), and multiple hepatic hemangiomas (Fig. 1E,F), which suggested that they had cardiovascular defects as well. We next investigated the expression pattern of Sprouty2 and Sprouty4 in endothelial cells during embryonic development, and found that Sprouty2 and Sprouty4 were more highly expressed in blood endothelial cells (BECs) than in lymphatic endothelial cells (LECs) (Fig. 1G).
###end p 11
###begin title 12
###xml 20 37 20 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Characterization of Sprouty2/Sprouty4 DKO mice.
###end title 12
###begin p 13
###xml 50 67 50 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 243 260 243 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 399 416 399 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 485 493 485 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 717 721 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nrp1</italic>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD44</italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYVE1</italic>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prox1</italic>
(A, B) Gross appearance of wild-type (WT) (A) and Sprouty2/Sprouty4 DKO (B) embryos at embryonic day 12.5. The arrow and arrowheads indicate hemorrhage and edema, respectively. (C, D) Hematoxylin-eosin (H&E) staining of sections of WT (C) and Sprouty2/Sprouty4 DKO (D) skin. (E, F) H&E staining and immunohistochemical staining with von Willebrand factor (vWF) of sections of hepatic hemangiomas in Sprouty2/Sprouty4 DKO liver. vWF was used as a blood vessel marker. (G) Expression of Sproutys in endothelial cells. About 5.0x104 BECs and LECs were FACS-sorted at embryonic day 14.5, and were used for RT-PCR analysis. GAPDH served as a loading control. Good separation of BECs and LECs was confirmed by BEC markers (Nrp1, CD44) and LEC markers (LYVE1, Prox1). Scale bars (C-F): 100 microm.
###end p 13
###begin p 14
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi2">[21]</xref>
###xml 169 177 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 272 281 272 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g002">Fig. 2A,B</xref>
###xml 363 371 363 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 485 493 485 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 503 512 503 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g002">Fig. 2C,D</xref>
###xml 605 613 605 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 637 646 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g002">Fig. 2A&#8211;D</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-DAmato1">[22]</xref>
###xml 955 963 955 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1026 1033 1026 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g002">Fig. 2E</xref>
###xml 1101 1109 1101 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 822 828 <span type="species:ncbi:10090">murine</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1113 1117 <span type="species:ncbi:10090">mice</span>
###xml 1133 1137 <span type="species:ncbi:10090">mice</span>
This discovery led us to examine vascularization in adult Sprouty4 single KO mice in detail, although Sprouty4 single KO mice showed no obvious vascular phenotype [21]. Sprouty4 single KO mice exhibited more vascular networks of blood vessels in the ear than WT mice did (Fig. 2A,B). Similarly, more vascular networks of blood vessels in the ear were observed in Sprouty2 single KO mice than in WT mice (data not shown). The numbers of blood vessels in the skin were also increased in Sprouty4 KO mice (Fig. 2C,D). Lymphatic vessel networks, on the other hand, were present at the same frequency in these Sprouty4 KO mice as in WT mice (Fig. 2A-D). Retinal vasculature is a good model system for the study of general blood vessel development [22]. Vascular development in the early embryo is difficult to observe, but the murine retinal vascular system develops after birth and is therefore easier to examine. We compared flat-mounted retinas from WT and Sprouty4 KO mice at postnatal day (PD) 3 after injecting FITC-dextran (Fig. 2E). As the image clearly shows, retinal angiogenesis was enhanced in Sprouty4 KO mice compared to WT mice.
###end p 14
###begin title 15
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Blood and lymphatic vessels of Sprouty4 single KO mice.
###end title 15
###begin p 16
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 324 325 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 415 423 413 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 702 703 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 775 783 771 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
(A) Blood vessels (green) and lymphatic vessels (red) in the ears of WT and Sprouty4 KO mice (8 weeks old) were analyzed by whole-mount immunohistochemical staining with anti-PECAM-1/CD31Ab and anti-LYVE-1 Ab, respectively. (B) CD31-positive vessel area or LYVE1-positive area was quantified. Data shown are means+/-SEM. *: P<0.05. (C) Blood vessels (green) and lymphatic vessels (red) in the dorsal skin of WT and Sprouty4 KO mice (8 weeks old) were analyzed by immunohistochemical staining with anti-PECAM-1/CD31Ab and anti-LYVE-1 Ab, respectively. Nuclei were stained with Hoechst 33342 dye (Blue). (D) CD31-positive vessel area or LYVE1-positive area was quantified. Data shown are means+/-SEM. *: P<0.05. (E) FITC-dextran-perfused flat-mounted retinal samples of WT and Sprouty4 KO mice at postnatal day 3. Scale bars (A, C): 100 microm.
###end p 16
###begin p 17
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
These data suggest that, in contrast to Spred1 and Spred2, which are important negative regulators of developmental lymphangiogenesis rather than developmental angiogenesis, as previously reported [18], Sprouty2 and Sprouty4 are important negative regulators of developmental angiogenesis rather than developmental lymphangiogenesis.
###end p 17
###begin title 18
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Sprouty4 KO mice are more resistant to ischemia
###end title 18
###begin p 19
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 197 205 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sasaki3">[23]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Tepper1">[24]</xref>
###xml 302 310 302 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 326 334 326 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 372 380 372 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi2">[21]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taketomi1">[25]</xref>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 223 228 <span type="species:ncbi:10090">mouse</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
Next, we sought to investigate the effect of Sprouty4 deficiency in the ischemia-induced angiogenesis model, an adult neovascularization assay which is useful for quantifying neovascularization in Sprouty4 KO mice. We used mouse models of hind limb ischemia [23] and soft tissue ischemia [24]. We used Sprouty4 KO mice, since Sprouty4 KO mice can survive much longer than Sprouty2 KO mice [21], [25].
###end p 19
###begin p 20
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 109 116 109 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g003">Fig. 3A</xref>
###xml 119 127 119 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 336 344 336 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 380 389 380 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g003">Fig. 3B,C</xref>
###xml 476 484 476 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 516 523 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g003">Fig. 3D</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
The former model revealed that Sprouty4 KO mice were more resistant to hind limb ischemia than WT mice were (Fig. 3A). Sprouty4 KO mice showed a significantly elevated recovery of limb perfusion after induction of hind limb ischemia as compared with WT mice, and the ischemic/non-ischemic leg perfusion ratio was much more favorable in Sprouty4 KO mice than in WT mice (P<0.001) (Fig. 3B,C). Additionally, angiogenesis in the ischemic hind limb was significantly increased in Sprouty4 KO mice compared with WT mice (Fig. 3D).
###end p 20
###begin title 21
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Sprouty4 KO mice are more resistant in a hind-limb ischemia model.
###end title 21
###begin p 22
###xml 330 338 330 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 470 471 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 569 577 567 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 803 804 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
(A) Representative photos of ischemic limbs, indicated by arrows. (B) Representative laser Doppler images for each group are depicted. Arrowheads indicate ischemic limbs. The interval of low perfusion is displayed as dark blue; the highest perfusion interval is displayed as red. (C) Recovery of limb perfusion in WT (n = 10) and Sprouty4 KO (n = 7) mice after hind limb ischemia as assessed by laser Doppler blood flow analysis on day 14. Data shown are means+/-SD. *: P<0.001. (D) Blood vessels (green) in the non-ischemic or ischemic adductor muscles of male WT and Sprouty4 KO mice (8-10 weeks old) were analyzed by immunohistochemical staining with anti-PECAM-1/CD31Ab. Nuclei were stained with Hoechst 33342 dye (blue). The CD31-positive vessel area was quantified. Data shown are means+/-SEM. *: P<0.05. Scale bars: (D) 100 microm.
###end p 22
###begin p 23
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g004">Fig. 4A</xref>
###xml 442 450 442 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 558 565 558 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g004">Fig. 4B</xref>
###xml 581 589 581 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 747 755 747 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 795 803 795 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 835 842 835 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g004">Fig. 4A</xref>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 175 180 <span type="species:ncbi:10090">mouse</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
The latter model was induced by creating lateral skin incisions on the dorsal surfaces of mice. The overlying skin was undermined, and a silicone sheet was inserted into each mouse to separate the skin from the underlying tissue bed. As a result, the most central portion of skin underwent the most severe ischemic insult, which, in WT mice, ultimately led to the absence of flow and necrosis in the central portion of the skin (Fig. 4A). In Sprouty4 KO mice, however, angiogenesis in the dorsal skin was significantly increased compared to that in WT mice (Fig. 4B). As a result, Sprouty4 KO mice were more resistant to soft tissue ischemia than WT mice were, and gross evidence of necrosis in the dorsal skin was more evident in WT mice than in Sprouty4 KO mice (100% and 16.7% in WT mice and Sprouty4 KO mice, respectively, n = 6) (Fig. 4A).
###end p 23
###begin title 24
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Sprouty4 KO mice are also more resistant in a soft tissue ischemia model.
###end title 24
###begin p 25
###xml 65 73 65 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 206 214 206 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 430 431 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
(A) Representative photos of ischemic dorsal skin of male WT and Sprouty4 KO mice (8-10 weeks old). Arrows indicate necrotic skin. (B) Left: Blood vessels (green) in the ischemic dorsal skin of male WT and Sprouty4 KO mice were analyzed by immunohistochemical staining with anti-PECAM-1/CD31Ab. Nuclei were stained with Hoechst 33342 dye (blue). Right: The CD31-positive vessel area was quantified. Data shown are means+/-SEM. *: P<0.05. Scale bars (B): 100 microm.
###end p 25
###begin p 26
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
These data show that Sprouty4 KO mice exhibit enhanced neovascularization in ischemia-induced models.
###end p 26
###begin title 27
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
Increased ischemia-induced neovascularization by in vivo shRNA targeting Sproutys
###end title 27
###begin p 28
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 84 93 84 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g002">Fig. 2C,D</xref>
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g003">Fig. 3D</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
The increased vessel density in the skin and muscles of untreated Sprouty4 KO mice (Fig. 2C,D, Fig. 3D) provides them with elevated blood-vessel area in these regions, which is partially responsible for their increased resistance to ischemia.
###end p 28
###begin p 29
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 225 233 225 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 254 262 254 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 355 362 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g005">Fig. 5A</xref>
###xml 390 407 390 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 463 471 463 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 489 495 489 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g001">Fig. 1</xref>
###xml 585 593 585 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sasaki2">[20]</xref>
###xml 627 635 627 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 640 648 640 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 768 777 768 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g005">Fig. 5B,C</xref>
###xml 797 806 797 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g005">Fig. 5D,E</xref>
###xml 852 860 852 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 865 873 865 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 921 929 921 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1001 1008 1001 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g005">Fig. 5F</xref>
###xml 1116 1124 1116 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 933 938 <span type="species:ncbi:10090">mouse</span>
###xml 1091 1097 <span type="species:ncbi:10090">murine</span>
To investigate in vivo the efficiency of down-regulating Sproutys as therapy for peripheral ischemic diseases, we administered ischemia treatment to the hind limbs of C57BL/6J mice, then injected shRNA targeting Sprouty2 and Sprouty4. We suppressed both Sprouty2 and Sprouty4 simultaneously, because both of the mRNAs increased during hind limb ischemia (Fig. 5A), because the phenotype of Sprouty2/Sprouty4 DKO mice demonstrated a redundant role of Sprouty2 and Sprouty4 in angiogenesis (Fig. 1), and because we have not found any functional differences between Sprouty2 and Sprouty4 in vitro[20]. The shRNA plasmid targeting Sprouty2 and Sprouty4 efficiently suppressed the expression levels of endogenous Sprouty2 and Sprouty4, respectively, in both real-time PCR (Fig. 5B,C) and Western blot (Fig. 5D,E) analysis. The shRNA plasmids targeting both Sprouty2 and Sprouty4 enhanced VEGF-A-induced ERK and Akt activation in vitro in mouse embryonic fibroblasts (MEFs), which stably expressed VEGFR-2 (Fig. 5F). We used MEFs because it has been very difficult to introduce shRNA into primary murine endothelial cells in vitro. Although we confirmed that shRNA against Sprouty2 or Sprouty4 alone enhanced VEGF-A-induced ERK and Akt activation (data not shown), we observed much stronger effect by the combination of Sprouty2 and Sprouty4 shRNAs. Thus we decide to use combination of both Sprouty2 and Sprouty4 shRNAs for further experiments.
###end p 29
###begin title 30
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
In vivo effects of shRNA targeting Sprouty2 and Sprouty4.
###end title 30
###begin p 31
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 168 176 168 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 282 290 282 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 304 312 304 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 460 468 460 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 482 490 482 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 632 640 632 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 645 653 645 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 790 807 790 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
(A) The in vivo effects of shRNA plasmids targeting Sproutys in the hind limb model were evaluated by RT-PCR analysis. (B, C) Real-time PCR analysis of Sprouty2 (B) or Sprouty4 (C) mRNA expression in MEFs stably infected with control retroviruses and retroviruses expressing either Sprouty2 shRNA (B) or Sprouty4 shRNA (C). (D, E) Western blot analysis of protein extracts from MEFs stably infected with control retroviruses and retroviruses expressing either Sprouty2 shRNA (D) or Sprouty4 shRNA (E). The relative intensities of Sprouty2 and Sprouty4 bands normalized by STAT5 expression levels are shown above. (F) Effect of both Sprouty2 and Sprouty4 knockdown on ERK and Akt activities. MEFs stably expressing VEGFR-2 were infected with control retroviruses and retroviruses expressing Sprouty2/Sprouty4 shRNA, and stimulated with 100 ng/mL VEGF-A. Cell extracts were immunoblotted with the indicated antibodies.
###end p 31
###begin p 32
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 218 227 218 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g006">Fig. 6A&#8211;C</xref>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 268 276 268 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 421 429 421 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 434 441 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
First, we showed that injection of shRNA plasmids targeting Sprouty2 and Sprouty4 significantly enhanced corneal neovascularization induced by VEGF-A, compared to control shRNA plasmids in a corneal micropocket assay (Fig. 6A-C). These data indicate that Sprouty2 and Sprouty4 shRNA plasmids can efficiently suppress the expression levels of Sprouty2 and Sprouty4 and block the effect of endogenous Sprouty2 and Sprouty4 in vitro and in vivo.
###end p 32
###begin title 33
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
In vivo effects of shRNA targeting Sprouty2 and Sprouty4 in corneal micropocket assay.
###end title 33
###begin p 34
###xml 365 366 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 405 406 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
(A) Corneal neovascularization was induced by mouse VEGF-A (200 ng) on day 12 after hydron pellets had been implanted into male BALB/c mouse corneas. After implantation, 10 microg shRNA plasmids per eye were delivered by subconjunctival injection. Representative photos are shown. (B) Quantitative analysis of neovascularization on day 12. Areas are expressed in mm2. Bars show the mean+/-SEM (n = 5). *: P<0.05. (C) Sections of corneas implanted with VEGF-A stained by anti-PECAM-1/CD31Ab on day 12. Scale bars (C): 100 microm.
###end p 34
###begin p 35
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 170 178 170 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 228 236 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 248 255 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 257 264 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g005">Fig. 5A</xref>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 280 288 280 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 512 513 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 521 530 521 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g007">Fig. 7A,B</xref>
###xml 558 566 558 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 571 579 571 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 651 658 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g007">Fig. 7C</xref>
###xml 750 757 750 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Next, we investigated whether Sprouty2 and Sprouty4 shRNA plasmids were effective in a mouse model of hind limb ischemia. Upon injection to the ischemic adductor muscle, Sprouty2 and Sprouty4 shRNA plasmids reduced Sprouty2 and Sprouty4 expression in vivo (Fig. 5A). Sprouty2 and Sprouty4 shRNA plasmids induced a significantly elevated recovery of limb perfusion after induction of hind limb ischemia as compared with control shRNA plasmids, and markedly improved the ischemic/non-ischemic leg perfusion ratio (P<0.05) (Fig. 7A,B). shRNA plasmids targeting Sprouty2 and Sprouty4 also increased capillary density compared with control shRNA plasmids (Fig. 7C). Our data clearly demonstrate that Sprouty2 and Sprouty4 negatively regulate angiogenesis in vivo and would make good therapeutic targets for peripheral ischemic diseases.
###end p 35
###begin title 36
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 67 88 67 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2 and Sprouty4</italic>
Increased ischemia-induced angiogenesis by in vivo shRNA targeting Sprouty2 and Sprouty4.
###end title 36
###begin p 37
###xml 320 337 320 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 476 477 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 593 610 591 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2/Sprouty4</italic>
###xml 787 788 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
(A) Representative laser Doppler images for each group are depicted. Arrowheads indicate ischemic limbs. The interval of low perfusion is displayed as dark blue; the highest perfusion interval is displayed as red. (B) Recovery of limb perfusion in C57BL/6J mice (8 weeks old) injected with the control shRNA (n = 10) or Sprouty2/Sprouty4 shRNA vectors (n = 12) after hind limb ischemia as assessed by laser Doppler blood flow analysis on day 14. Data shown are means+/-SD. *: P<0.05. (C) Blood vessels (green) in the non-ischemic or ischemic adductor muscle injected with the control shRNA or Sprouty2/Sprouty4 shRNA vectors stained with anti-PECAM-1/CD31Ab. Nuclei were stained with Hoechst 33342 dye (blue). The CD31-positive vessel area was quantified. Data shown are means+/-SEM. *: P<0.05. Scale bars (C): 100 microm.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 137 145 137 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 370 378 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 496 504 496 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 514 522 514 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 666 674 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 679 687 679 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 699 706 699 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
In this study, we investigated the physiological function of Sproutys in angiogenesis by performing a knockout and knockdown analysis of Sproutys. In contrast to Spred1 and Spred2, which regulate developmental lymphangiogenesis, Sprouty2 and Sprouty4 are important negative regulators of developmental angiogenesis in vivo. We found that the amounts of blood vessels in Sprouty4 KO mice are increased in all tissues we investigated. So we think that all peripheral blood vessels are increased in Sprouty4 KO mice. Sprouty4 deficiency enhanced ischemia-induced angiogenesis in mouse models of hind limb ischemia and soft tissue ischemia. Moreover, the suppression of Sprouty2 and Sprouty4 expression in vivo by shRNA targeting had a therapeutic effect in our model of hind limb ischemia, indicating that Sproutys should be novel therapeutic targets for treating peripheral ischemic diseases.
###end p 39
###begin p 40
###xml 63 81 63 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sivak1">[26]</xref>
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 351 358 347 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty</italic>
###xml 363 368 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spred</italic>
###xml 497 501 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sivak1">[26]</xref>
###xml 529 537 525 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 593 599 589 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spreds</italic>
###xml 653 660 649 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g001">Fig. 1G</xref>
###xml 670 674 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
###xml 850 854 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
###xml 997 1001 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Wang1">[27]</xref>
###xml 1002 1006 998 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Kuhnert1">[29]</xref>
###xml 1031 1038 1027 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty</italic>
###xml 1131 1136 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spred</italic>
###xml 1249 1253 1245 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
###xml 1265 1273 1261 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 1278 1286 1274 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1378 1391 1374 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spred1/Spred2</italic>
###xml 1490 1496 1486 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g002">Fig. 2</xref>
###xml 1506 1510 1502 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
###xml 1841 1844 1833 1836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Takahashi1">[4]</xref>
###xml 1932 1950 1924 1942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 63 81 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 1304 1308 <span type="species:ncbi:10090">mice</span>
###xml 1396 1400 <span type="species:ncbi:10090">mice</span>
###xml 1932 1950 <span type="species:ncbi:8364">Xenopus tropicalis</span>
The roles of Sprouty and Spred proteins during gastrulation in Xenopus tropicalis have been compared elsewhere [26]. Spred proteins preferentially inhibit the Ras/ERK cascade that directs mesoderm formation, whereas Sprouty proteins block the Ca2+ and PKCdelta signals required for morphogenetic movements during gastrulation. Thus, the expression of Sprouty and Spred genes at specific times during gastrulation might redirect FGF signals toward mesoderm formation or morphogenesis, respectively [26]. In mammalian development, Sproutys are expressed mainly in blood endothelial cells, while Spreds are expressed mainly in lymphatic endothelial cells (Fig. 1G and Ref. [18]). In overexpression experiments, while Sproutys can inhibit VEGF-A signaling but not VEGF-C signaling, Spreds can suppress both types (Taniguchi K., unpublished data and Ref. [18]). Indeed, microRNA-126 deletion suppresses VEGF-A-induced ERK activation in endothelial cells and angiogenesis through the increase of Spred1 [27]-[29]. However, the effect of Sprouty deletion is more specific to VEGF-A signaling than to VEGF-C signaling, while the effect of Spred deletion is more specific to VEGF-C signaling than to VEGF-A signaling (Taniguchi K., unpublished data and Ref. [18]). In fact, Sprouty2 and Sprouty4 single-deficient mice showed defects of blood vessels rather than lymphatic vessels, while Spred1/Spred2 DKO mice showed abnormal lymphatic vessel development and nearly normal blood vessel development (Fig. 2 and Ref. [18]). In addition to this difference in expression, these results suggest that Sproutys and Spreds might have different functions in endothelial cells. VEGF-A/VEGFR-2 signaling is Ras-independent and PLC-gamma/PKC-dependent, while VEGF-C/VEGFR-3 signaling is Ras-dependent and PKC-independent (Taniguchi K., unpublished data and Ref. [4]). Therefore, drawing an analogy from the different functions of Sproutys and Spreds in Xenopus tropicalis, we propose that Sproutys inhibit PLC-gamma/PKC-dependent VEGF-A signaling and angiogenesis, while Spreds inhibit Ras-dependent VEGF-C signaling and lymphangiogenesis.
###end p 40
###begin p 41
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Schalch1">[30]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Hanahan1">[12]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Hannun1">[14]</xref>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bFGF</italic>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Masaki1">[31]</xref>
###xml 424 427 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Kim1">[1]</xref>
###xml 429 432 429 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Mason1">[2]</xref>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty</italic>
###xml 575 582 575 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g005">Fig. 5F</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Ayada1">[19]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi2">[21]</xref>
###xml 660 667 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SHP-1</italic>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sugano1">[32]</xref>
###xml 871 879 871 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 725 728 <span type="species:ncbi:10116">rat</span>
Although, in ischemia-induced angiogenesis, VEGF-A is thought to be the primary angiogenesis-stimulating factor [30], angiogenesis is the more complex process, as it is triggered not only by VEGF-A but also by bFGF, S1P, angiopoietins, and others [12]-[14]. In fact, it is reported that bFGF gene therapy is effective to treat critically ischemic limb [31]. It is already known that Sproutys can inhibit various RTK signals [1], [2]. We have also shown that loss of Sprouty expression results in hyperactivation of VEGF-A and bFGF signaling as well as S1P and LPA signaling (Fig. 5F, Taniguchi K., unpublished data and Ref. [19] and [21]). It is reported that in vivo shRNA targeting SHP-1 also accelerated angiogenesis in a rat model of hind limb ischemia [32]. While SHP-1 inhibits only RTK signals, Sproutys suppress both RTK and GPCR signals. Thus the suppression of Sproutys could be beneficial.
###end p 41
###begin p 42
###xml 570 577 570 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty</italic>
###xml 655 659 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Antoine1">[33]</xref>
###xml 688 701 688 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty/Spred</italic>
###xml 952 960 952 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1009 1016 1009 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1033 1041 1033 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
Inhibition of negative feed-back loops leading to profound and long term activation of signals often lead to a dysregulation of neovascularisation since the overshooting response is inducing immature vessels. However, excessive sprouting in response to inhibition of Sproutys results in the formation of mature vessels. Angiogenesis is a complex process that includes the recruitment and proliferation of various cells, such as endothelial cells, mural cells [smooth muscle cells (SMC) and pericytes], endothelial progenitor cells (EPCs) and others. It is reported that Sprouty-family genes are expressed in both endothelial cells and smooth muscle cells [33], and we have confirmed that Sprouty/Spred family genes are also expressed in bone marrow (Taniguchi K., unpublished data). It is possible that Sproutys function not only in endothelial cells, but also in mural cells, EPCs or myeloid cells, and that enhanced angiogenesis of mature vessels in Sprouty4 KO mice and the results of our experiments with in vivo shRNA targeting Sproutys are partially dependent on the enhanced function or the increased number of mural cells, EPCs or myeloid cells. Moreover, it is possible that Sproutys are also associated with angiopoietins signals, which are important for the maturation of blood vessels. Further study is necessary to investigate these possibilities.
###end p 42
###begin p 43
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 96 102 96 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g003">Fig. 3</xref>
###xml 104 110 104 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g004">Fig. 4</xref>
###xml 201 209 201 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 289 297 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 302 310 302 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 376 382 376 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g007">Fig. 7</xref>
###xml 432 440 432 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 491 499 491 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005467-g005">Fig. 5A</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Takeshita1">[34]</xref>
###xml 838 846 838 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 851 859 851 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1082 1090 1082 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
Sprouty4 KO mice were more resistant to ischemia than WT mice were in mouse models of ischemia (Fig. 3, Fig. 4), and neovascularization induced by a tumor transplantation model was also accelerated by Sprouty4 deficiency (Taniguchi K., unpublished data). Moreover, in vivo shRNA targeting Sprouty2 and Sprouty4 accelerated angiogenesis in a mouse model of hind limb ischemia (Fig. 7). In this study, muscle tissue injected with the Sproutys shRNA vectors exhibited a significant decrease in Sproutys transcripts (Fig. 5A). This knockdown efficiency may be due to the fact, in skeletal muscle, the efficiency of intramuscular gene transfer has been shown to be augmented from five- to seven-fold when the injected muscle is ischemic [34]. The present study is the first to uncover these significant implications for gene therapy using the Sprouty2 and Sprouty4 shRNA vectors for the treatment of peripheral ischemic diseases. The fact that Sproutys exhibit such broad suppression activity, inhibiting a wide variety of angiogenic factors and cells, indicates that the suppression of Sproutys must enhance neovascularization.
###end p 43
###begin p 44
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In conclusion, Sproutys are physiologically important regulators of angiogenesis in vivo and may be useful as new therapeutic targets for peripheral ischemic diseases.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 46
###begin p 47
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi2">[21]</xref>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taketomi1">[25]</xref>
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
Sprouty2 KO mice and Sprouty4 KO mice have been described previously [21], [25]. Sprouty2 KO mice and Sprouty4 KO mice were generated as 129/C57BL/6J mixed background, and then backcrossed into C57BL/6J at least five times. Gender-matched, WT littermates were used as controls. All experiments using these mice were approved by and performed according to the guidelines of the Animal Ethics Committee of Kyushu University, Fukuoka, Japan.
###end p 47
###begin title 48
Cell culture
###end title 48
###begin p 49
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi2">[21]</xref>
###xml 564 568 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
###xml 570 574 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Nishinakamura1">[35]</xref>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 211 217 <span type="species:ncbi:9913">bovine</span>
Primary mouse embryonic fibroblasts (MEFs) were prepared, as previously described [21]. MEFs were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum, penicillin and streptomycin. To generate MEFs stably expressing VEGFR-2 or shRNAs, MEFs were infected with the retroviruses produced by Plat-E, packaging cell line, transfected with pMX-VEGFR-2 or shRNA plasmids, and then the infected cells were selected with 1 microg/ml puromycin (Invivogen, San Diego, CA, USA), as previously described [18], [35].
###end p 49
###begin title 50
Antibodies and reagents
###end title 50
###begin p 51
###xml 380 385 <span type="species:ncbi:10090">Mouse</span>
###xml 448 453 <span type="species:ncbi:9606">Human</span>
Antibodies used in this experiment were as follows: anti-phospho-ERK1/2 (#9106), anti-phospho-Akt (#4058), and anti-Akt (#9272) (Cell Signaling Technology, Danvers, MA, USA); anti-Sprouty4 (H-100), anti-VEGFR-2 (A-3) and anti-ERK2 (C-14) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-Sprouty2 (ab50317) (Abcam, Cambridge, MA, USA); and anti-vWF (DAKO, Glostrup, Denmark); Mouse VEGF-A was purchased from R&D Systems (Minneapolis, MN, USA). Human VEGF-A was purchased from PeproTech (London, UK).
###end p 51
###begin title 52
RT-PCR and real-time PCR analysis
###end title 52
###begin p 53
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nrp1</italic>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD44</italic>
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYVE-1</italic>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prox1</italic>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 742 750 742 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 754 783 754 783 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TTTTAATCCACCGATTGCTTGG-3&#8242;</named-content>
###xml 785 793 785 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 797 825 797 825 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTGCACTCGGATTATTCCATC-3&#8242;</named-content>
###xml 827 835 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 839 870 839 870 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGCTCCTCAAAGACCCCTAGAAGC-3&#8242;</named-content>
###xml 872 880 872 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 884 915 884 915 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGCTGCTACTGCTGCTTACAGAGC-3&#8242;</named-content>
###xml 917 922 917 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 926 952 926 952 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCACAGTCCATGCCATCAC-3&#8242;</named-content>
###xml 957 962 957 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 965 991 965 991 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCACCACCCTGTTGCTGTA-3&#8242;</named-content>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Morisada1">[36]</xref>
###xml 1277 1279 1277 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1276 1279 1276 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;<italic>Ct</italic></sup>
###xml 1287 1289 1287 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1325 1327 1325 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1385 1390 1385 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1456 1464 1456 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 1468 1497 1468 1497 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATAATCCGAGTGCAGCCTAAATC-3&#8242;</named-content>
###xml 1499 1507 1499 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 1511 1537 1511 1537 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCAGTCCTCACACCTGTAG-3&#8242;</named-content>
###xml 1539 1547 1539 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1551 1578 1551 1578 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGACCAGAGGCTCCTAGATCA-3&#8242;</named-content>
###xml 1580 1588 1580 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1592 1618 1592 1618 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGCGGCTTACAGTGAACCA-3&#8242;</named-content>
###xml 1620 1625 1620 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1629 1655 1629 1655 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTGTCCGTCGTGGATCTGA-3&#8242;</named-content>
###xml 1660 1665 1660 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1668 1695 1668 1695 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGCTTCACCACCTTCTTGA-3&#8242;</named-content>
The cells or tissues were lysed in RNAiso (TAKARA BIO, Shiga, Japan) for RNA preparation. Total RNA was isolated through fluorescence activated cell sorting (FACS), which sorted about 5.0x104 BECs and LECs at embryonic day 14.5, as previously reported [18]. Good separation of BECs and LECs was confirmed by BEC markers (Nrp1, CD44) and LEC markers (LYVE-1, Prox1). Total RNA was reverse transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA), and the product was used for further analysis. PCR products were separated on 2.0% agarose gel stained with ethidium bromide. The expression level of GAPDH was evaluated as an internal control. The primer sequences for RT-PCR were as follows: Sprouty2-F, 5'- TTTTAATCCACCGATTGCTTGG-3'; Sprouty2-R, 5'-GCTGCACTCGGATTATTCCATC-3'; Sprouty4-F, 5'-CAGCTCCTCAAAGACCCCTAGAAGC-3'; Sprouty4-R, 5'-GTGCTGCTACTGCTGCTTACAGAGC-3'; GAPDH-F, 5'-ACCACAGTCCATGCCATCAC-3' and GAPDH-R 5'-TCCACCACCCTGTTGCTGTA-3'. The primer sequences for BEC and LEC markers were described elsewhere [36]. Real-time PCR was performed on cDNA samples using an ABI 7000 Sequence Detection System (Applied Biosystems) with the SYBR Green system (Applied Biosystems). The relative quantitation value is expressed as 2-Ct, where Ct is the difference between the mean Ct value of triplicates of the sample and of the endogenous GAPDH control. The primer sequences for real-time PCR were as follows: Sprouty2-F, 5'-ATAATCCGAGTGCAGCCTAAATC-3'; Sprouty2-R, 5'-CGCAGTCCTCACACCTGTAG-3'; Sprouty4-F, 5'-CGACCAGAGGCTCCTAGATCA-3'; Sprouty4-R, 5'-CAGCGGCTTACAGTGAACCA-3'; GAPDH-F, 5'-TGTGTCCGTCGTGGATCTGA-3' and GAPDH-R 5'-CCTGCTTCACCACCTTCTTGA-3'.
###end p 53
###begin title 54
Western blot analysis
###end title 54
###begin p 55
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
Western blot analysis was performed as described previously [18]. MEFs were lysed in lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 1 mM sodium vanadate) supplemented with protease inhibitors (Nacalai tesque, Kyoto, Japan). About 20 microg of proteins were separated by SDS-PAGE and transferred to Immobilon-P nylon membranes (Millipore, Bedford, MA, USA).
###end p 55
###begin title 56
Immunohistochemistry
###end title 56
###begin p 57
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Taniguchi1">[18]</xref>
Whole-mount immunohistochemistry of adult ears or immunohistochemistry of adult skin was performed with 1:200 diluted anti-PECAM-1/CD31 (MEC13.3, BD Pharmingen, Franklin Lakes, NJ, USA) or anti-LYVE-1 antibody (Acris Antibodies, Hiddenhausen, Germany) essentially as described previously [18].
###end p 57
###begin title 58
Retinal angiography
###end title 58
###begin p 59
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-DAmato1">[22]</xref>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Flat-mounted retinas were evaluated using fluorescein-dextran angiography as described elsewhere [22]. The mice were deeply anesthetized and a 0.03 ml/g body weight 50 mg/mL solution of 2x106 molecular weight FITC-dextran (Sigma, St Louis, MO, USA) was perfused through the left ventricle. The eyes were enucleated and fixed in 4% paraformaldehyde for at least 3 h. The corneas and lenses were then removed, and the peripheral retinas were dissected and flat-mounted on microscope slides for examination under a fluorescence microscope.
###end p 59
###begin title 60
Vessel quantitative analysis
###end title 60
###begin p 61
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Tammela1">[37]</xref>
The vascular area in the ear, skin or muscle was quantified as a PECAM-1/CD31-positive area from ten x10 micrographs, using Image J software (), as described elsewhere [37]. LYVE-1-positive vessels in the skin were quantified in a similar manner.
###end p 61
###begin title 62
RNAi-mediated knockdown
###end title 62
###begin p 63
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 162 170 162 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 180 205 180 205 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCGGGTTGTCGTTGTAAA-3&#8242;</named-content>
###xml 250 259 250 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mSprouty2</italic>
###xml 268 276 268 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 433 441 433 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 446 454 446 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 745 748 745 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Brems1">[9]</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Nishinakamura1">[35]</xref>
###xml 125 131 <span type="species:ncbi:10090">murine</span>
###xml 261 267 <span type="species:ncbi:10090">Murine</span>
The mammalian expression vector pSUPER.retro.puro (Oligoengine, Seattle, WA, USA) was used for expression of shRNA targeting murine Sprouty2. The sequence of the Sprouty2 shRNA is 5'-GCCGGGTTGTCGTTGTAAA-3' and corresponds to nucleotides 1150-1168 of mSprouty2. Murine Sprouty4 shRNA (29-mer) and control plasmids were purchased from Origene (Rockville, MD, USA) and used according to the manufacturer's protocols. The specificity of Sprouty2 and Sprouty4 knockdown was confirmed by real-time PCR or immunoblotting of whole-cell lysates of MEFs with anti-Sprouty2 and anti-Sprouty4 antibodies, respectively. The relative intensities of Sprouty2 or Sprouty4 band were normalized by STAT5 expression using Image J software, as previously described [9], [35].
###end p 63
###begin title 64
In vivo models of ischemia
###end title 64
###begin p 65
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sasaki3">[23]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Chavakis1">[38]</xref>
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1081 1088 1075 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1105 1113 1099 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 1118 1126 1112 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1238 1246 1228 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sproutys</italic>
###xml 1272 1280 1258 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty2</italic>
###xml 1308 1316 1290 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sprouty4</italic>
###xml 1459 1463 1441 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Sugano1">[32]</xref>
###xml 1532 1536 1514 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Tepper1">[24]</xref>
###xml 1538 1542 1520 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Kimura1">[39]</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 1050 1053 <span type="species:ncbi:10116">rat</span>
###xml 1453 1458 <span type="species:ncbi:10090">mouse</span>
###xml 1674 1678 <span type="species:ncbi:10090">mice</span>
A hind limb ischemia model was performed as previously described [23], [38]. Male WT and Sprouty4 KO mice (8-10 weeks old) and male C57BL/6J mice (8 weeks old) were used for a hind limb ischemia model. The proximal portion of the right femoral artery including the superficial and the deep branch and the distal portion of the saphenous artery were occluded with an electrical coagulator. After 2 weeks, we determined the ischemic (right)/nonischemic (left) limb blood flow ratio by using a laser Doppler blood flow imager (Laser Doppler Perfusion Imager System, moorLDI-Mark 2; Moor Instruments, Wilmington, DE, USA). Before initiating scanning, mice were placed on a heating pad at 37degreesC to minimize variations in their body temperatures. Calculated perfusion is expressed as the ratio of ischemic to nonischemic hind limb perfusion. At 2 wk after femoral resection, adductor muscles from the ischemic and control limbs were embedded in OCT compound. Eight-micron sections were stained with anti-PECAM-1/CD31 antibody (BD Pharmingen) and anti-rat Ig secondary antibody. For in vivo shRNA targeting Sprouty2 and Sprouty4, a hind limb ischemia model was performed. Immediately after ischemia was induced, either a total of 40 microg Sproutys shRNA vectors (20 microg Sprouty2 shRNA vector and 20 microg Sprouty4 shRNA vector) or a quantity of control shRNA vectors was injected into five different sites in the adductor muscle of each anesthetized mouse [32]. A model of soft tissue ischemia similar to one described elsewhere [24], [39] was developed. The model consisted of lateral skin incisions (2.5 cm in length and 1.25 cm apart) created on the dorsal surface of mice, penetrating the skin, dermis, and underlying adipose tissue. The overlying skin was undermined, and a 0.13-mm-thick silicone sheet was inserted to separate the skin from the underlying tissue bed. The skin was then reapproximated with 6-0 nylon sutures.
###end p 65
###begin title 66
Corneal micropocket assay
###end title 66
###begin p 67
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005467-Nakao1">[40]</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
The mouse corneal micropocket assay and quantification of neovascularization were performed as described elsewhere [40], using male BALB/c mice (6-10 weeks old). For local delivery, shRNA plasmids (total 10 microg/10 microl per eye) were diluted in phosphate-buffered saline (PBS) and delivered subconjunctivally. The subconjunctival injections were given after hydron pellet implantation.
###end p 67
###begin title 68
Statistical analysis
###end title 68
###begin p 69
###xml 121 122 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 214 215 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are expressed as mean+/-SD or mean+/-SEM. Statistical significance was tested with an unpaired two-tailed Student's t-test or analysis of variance (ANOVA). The differences were considered to be significant if P<0.05.
###end p 69
###begin p 70
We thank T. Yoshioka, K. Fukuse, M. Asakawa, N. Shiino, H. Fujii, N. Kinoshita, M. Ohtsu, and Y. Yamada for technical assistance, and Y. Nishi and N. Soma for manuscript preparation. We also thank Dr. H. Nishinakamura for technical advice.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Modulation of signalling by Sprouty: a developing story.
###end article-title 72
###begin article-title 73
Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling.
###end article-title 73
###begin article-title 74
Sprouty proteins, masterminds of receptor tyrosine kinase signaling.
###end article-title 74
###begin article-title 75
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
###end article-title 75
###begin article-title 76
###xml 90 100 <span type="species:ncbi:7227">Drosophila</span>
sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways.
###end article-title 76
###begin article-title 77
Sprouty, an intracellular inhibitor of Ras signaling.
###end article-title 77
###begin article-title 78
Spred is a Sprouty-related suppressor of Ras signalling.
###end article-title 78
###begin article-title 79
Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation.
###end article-title 79
###begin article-title 80
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.
###end article-title 80
###begin article-title 81
Molecular mechanisms of vasculogenesis and embryonic angiogenesis.
###end article-title 81
###begin article-title 82
Angiogenesis in cancer, vascular, rheumatoid and other disease.
###end article-title 82
###begin article-title 83
Signaling vascular morphogenesis and maintenance.
###end article-title 83
###begin article-title 84
Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.
###end article-title 84
###begin article-title 85
Principles of bioactive lipid signalling: lessons from sphingolipids.
###end article-title 85
###begin article-title 86
Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells.
###end article-title 86
###begin article-title 87
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Inhibition of angiogenesis by a mouse sprouty protein.
###end article-title 87
###begin article-title 88
Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
###end article-title 88
###begin article-title 89
Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling.
###end article-title 89
###begin article-title 90
Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis.
###end article-title 90
###begin article-title 91
Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation.
###end article-title 91
###begin article-title 92
Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling.
###end article-title 92
###begin article-title 93
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse.
###end article-title 93
###begin article-title 94
Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
###end article-title 94
###begin article-title 95
Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells.
###end article-title 95
###begin article-title 96
Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia.
###end article-title 96
###begin article-title 97
FGF signal interpretation is directed by Sprouty and Spred proteins during mesoderm formation.
###end article-title 97
###begin article-title 98
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.
###end article-title 98
###begin article-title 99
miR-126 regulates angiogenic signaling and vascular integrity.
###end article-title 99
###begin article-title 100
###xml 42 48 <span type="species:ncbi:10090">murine</span>
Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126.
###end article-title 100
###begin article-title 101
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Homozygous deletion of early growth response 1 gene and critical limb ischemia after vascular ligation in mice: evidence for a central role in vascular homeostasis.
###end article-title 101
###begin article-title 102
Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.
###end article-title 102
###begin article-title 103
###xml 52 55 <span type="species:ncbi:10116">rat</span>
SiRNA targeting SHP-1 accelerates angiogenesis in a rat model of hindlimb ischemia.
###end article-title 103
###begin article-title 104
Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
###end article-title 104
###begin article-title 105
###xml 107 111 <span type="species:ncbi:10116">rats</span>
Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats.
###end article-title 105
###begin article-title 106
An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
###end article-title 106
###begin article-title 107
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.
###end article-title 107
###begin article-title 108
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.
###end article-title 108
###begin article-title 109
Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells.
###end article-title 109
###begin article-title 110
Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis.
###end article-title 110
###begin article-title 111
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.
###end article-title 111
###begin p 112
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 112
###begin p 113
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by Grants-in-Aid for Scientific Research (S) and for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the Naito Foundation, and the Astellas Foundation for Research on Metabolic Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 113

